SlideShare a Scribd company logo
1 of 16
CCR5 Δ32 AS A
POTENTIAL GENE
 THERAPY FOR
     AIDS
CONNOR ANDERSON, ALEXANDRA FULTON,
MEGAN SHELDON, VICTORIA SOEWARNA &
        AMANDA WORCESTER
MAKE SURE YOUR VOLUME IS
TURNED UP.

THERE ARE VOICEOVERS
THROUGHOUT THE
PRESENTATION.

PLEASE AND THANK YOU!
HIV ENTRY
DELTA 32
• Current deletion mutation that results in a frame shift

• 32 base pairs are absent from the gene sequence

   • THE CAT AND DOG RAN FOR FUN

               ∆A

   • THE CTA NDD OGR ANF ORF UN
CCR5 GENE SEQUENCE
TIMOTHY RAY BROWN
• Had HIV and Leukemia


• Leukemia was eradicated from the body


• HIV status was reversed


• Genetically altered genes into a vector


• Vector to cell line


• Gene therapy and treatment
THE BIG PICTURE
• Develop an easier gene therapy technique in hopes of
  curing HIV
SAMPLE COLLECTION
• Informed consent form
• Blood sample collected from
  AF2
• Purification of blood sample to
  collect lymphocytes (white
  blood cells)
• DNA purification
CCR5 SEQUENCE
DIGESTIONS
• Cut open vector to prepare for
  ligation
PLNCX2   MAP



               • Designed for retroviral
                 gene delivery and
                 expression
LIGATION

• Ligated oligonucleotides onto AF2
   • Converted BamHI into HINDIII site, and Xba
     into NOTI site.

• Made AF2 compatible for ligation into pLNCX2’s
  Multiple Cloning Site (MCS).
BACTERIAL TRANSFORMATION
TRANSDUCTION
• RNA is packaged into
  retroviral particles
• pLNCX2 does not
  contain the structural
  genes needed for
  particle formation
  replication
• Genes are stably
  integrated into PT67
• Retroviral particles can
  infect target cells
CULTURE CELLS
• U937 cells possess the CCR5 gene but do not
  express receptor
FUTURE PLANS
• Test for presence of CCR5 in U937 cells

More Related Content

What's hot

In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
Yordan Penev
 
Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
Crystal Rose
 
C L O N I N G
C L O N I N GC L O N I N G
C L O N I N G
kiran
 

What's hot (20)

In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
 
DNA sequencing
DNA sequencingDNA sequencing
DNA sequencing
 
REVERSE GENETICS
REVERSE GENETICSREVERSE GENETICS
REVERSE GENETICS
 
DNA Sequencing : Maxam Gilbert and Sanger Sequencing
DNA Sequencing : Maxam Gilbert and Sanger SequencingDNA Sequencing : Maxam Gilbert and Sanger Sequencing
DNA Sequencing : Maxam Gilbert and Sanger Sequencing
 
Duke neuro 1.10
Duke neuro 1.10Duke neuro 1.10
Duke neuro 1.10
 
Restriction enzyme
Restriction enzymeRestriction enzyme
Restriction enzyme
 
Recombinant DNA Technology (Key-Notes)
Recombinant DNA Technology (Key-Notes)Recombinant DNA Technology (Key-Notes)
Recombinant DNA Technology (Key-Notes)
 
Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
 
Applications and drawbacks of sanger sequencing
Applications and drawbacks of sanger sequencingApplications and drawbacks of sanger sequencing
Applications and drawbacks of sanger sequencing
 
Molecular markers
Molecular markersMolecular markers
Molecular markers
 
Dna sequencing techniques
Dna sequencing techniquesDna sequencing techniques
Dna sequencing techniques
 
DNA sequencing
DNA sequencingDNA sequencing
DNA sequencing
 
DNA sequencing by babar ali
DNA sequencing by babar aliDNA sequencing by babar ali
DNA sequencing by babar ali
 
Hoofdstuk 20 2008 deel 3
Hoofdstuk 20 2008 deel 3Hoofdstuk 20 2008 deel 3
Hoofdstuk 20 2008 deel 3
 
Rdna technology
Rdna technologyRdna technology
Rdna technology
 
Genome editing tools in plants
Genome editing tools in plantsGenome editing tools in plants
Genome editing tools in plants
 
C L O N I N G
C L O N I N GC L O N I N G
C L O N I N G
 
Maxam-Gilbert method of DNA sequencing
Maxam-Gilbert method of DNA sequencingMaxam-Gilbert method of DNA sequencing
Maxam-Gilbert method of DNA sequencing
 
Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
 
Gene sequencing technique
Gene sequencing techniqueGene sequencing technique
Gene sequencing technique
 

Similar to Sigma Xi

Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
Umair hanif
 
Geneticschapter7dnastructureandreplication 140305210513-phpapp01
Geneticschapter7dnastructureandreplication 140305210513-phpapp01Geneticschapter7dnastructureandreplication 140305210513-phpapp01
Geneticschapter7dnastructureandreplication 140305210513-phpapp01
Cleophas Rwemera
 
Genetics chapter 7 dna structure and replication
Genetics chapter 7 dna structure and replicationGenetics chapter 7 dna structure and replication
Genetics chapter 7 dna structure and replication
vanessawhitehawk
 
Eukaryotic Gene Regulation I 2014 slides
Eukaryotic Gene Regulation I 2014 slides Eukaryotic Gene Regulation I 2014 slides
Eukaryotic Gene Regulation I 2014 slides
Jill Howlin
 
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
pcpchic
 

Similar to Sigma Xi (20)

HIV Cure by Stem cell transplantation
HIV Cure by Stem cell transplantationHIV Cure by Stem cell transplantation
HIV Cure by Stem cell transplantation
 
Genetic engineering
Genetic engineeringGenetic engineering
Genetic engineering
 
G4 Presentation.pptx
G4 Presentation.pptxG4 Presentation.pptx
G4 Presentation.pptx
 
RDT, HGP, GENE THERAPY power point presentation
RDT, HGP, GENE THERAPY power point presentationRDT, HGP, GENE THERAPY power point presentation
RDT, HGP, GENE THERAPY power point presentation
 
Expanding the Genetic Code
Expanding the Genetic CodeExpanding the Genetic Code
Expanding the Genetic Code
 
Recombination DNA Technology
Recombination DNA TechnologyRecombination DNA Technology
Recombination DNA Technology
 
Geneticschapter7dnastructureandreplication 140305210513-phpapp01
Geneticschapter7dnastructureandreplication 140305210513-phpapp01Geneticschapter7dnastructureandreplication 140305210513-phpapp01
Geneticschapter7dnastructureandreplication 140305210513-phpapp01
 
Genetics chapter 7 dna structure and replication
Genetics chapter 7 dna structure and replicationGenetics chapter 7 dna structure and replication
Genetics chapter 7 dna structure and replication
 
Recombinant DNA technology
Recombinant DNA technologyRecombinant DNA technology
Recombinant DNA technology
 
Eukaryotic Gene Regulation I 2014 slides
Eukaryotic Gene Regulation I 2014 slides Eukaryotic Gene Regulation I 2014 slides
Eukaryotic Gene Regulation I 2014 slides
 
Recombinant dna technology
Recombinant dna technologyRecombinant dna technology
Recombinant dna technology
 
Recombinant dna technology
Recombinant dna technologyRecombinant dna technology
Recombinant dna technology
 
VIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFERVIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFER
 
Recombinent DNA
Recombinent DNA Recombinent DNA
Recombinent DNA
 
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
Strategies to Characterize Functional Regions of the Varicella-Zoster Virus E...
 
DNA_and_inheritance.ppt
DNA_and_inheritance.pptDNA_and_inheritance.ppt
DNA_and_inheritance.ppt
 
Dna and genes
Dna and genesDna and genes
Dna and genes
 
Genetic Engineering : Recombinant DNA Technology, vectors And Ti Plasmid
Genetic Engineering : Recombinant DNA Technology, vectors And Ti PlasmidGenetic Engineering : Recombinant DNA Technology, vectors And Ti Plasmid
Genetic Engineering : Recombinant DNA Technology, vectors And Ti Plasmid
 
Recombinant DNA-PPT.pptx
Recombinant DNA-PPT.pptxRecombinant DNA-PPT.pptx
Recombinant DNA-PPT.pptx
 
Recombinant DNA-PPT.pptx
Recombinant DNA-PPT.pptxRecombinant DNA-PPT.pptx
Recombinant DNA-PPT.pptx
 

Recently uploaded

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 

Recently uploaded (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 

Sigma Xi

  • 1. CCR5 Δ32 AS A POTENTIAL GENE THERAPY FOR AIDS CONNOR ANDERSON, ALEXANDRA FULTON, MEGAN SHELDON, VICTORIA SOEWARNA & AMANDA WORCESTER
  • 2. MAKE SURE YOUR VOLUME IS TURNED UP. THERE ARE VOICEOVERS THROUGHOUT THE PRESENTATION. PLEASE AND THANK YOU!
  • 4. DELTA 32 • Current deletion mutation that results in a frame shift • 32 base pairs are absent from the gene sequence • THE CAT AND DOG RAN FOR FUN ∆A • THE CTA NDD OGR ANF ORF UN
  • 6. TIMOTHY RAY BROWN • Had HIV and Leukemia • Leukemia was eradicated from the body • HIV status was reversed • Genetically altered genes into a vector • Vector to cell line • Gene therapy and treatment
  • 7. THE BIG PICTURE • Develop an easier gene therapy technique in hopes of curing HIV
  • 8. SAMPLE COLLECTION • Informed consent form • Blood sample collected from AF2 • Purification of blood sample to collect lymphocytes (white blood cells) • DNA purification
  • 10. DIGESTIONS • Cut open vector to prepare for ligation
  • 11. PLNCX2 MAP • Designed for retroviral gene delivery and expression
  • 12. LIGATION • Ligated oligonucleotides onto AF2 • Converted BamHI into HINDIII site, and Xba into NOTI site. • Made AF2 compatible for ligation into pLNCX2’s Multiple Cloning Site (MCS).
  • 14. TRANSDUCTION • RNA is packaged into retroviral particles • pLNCX2 does not contain the structural genes needed for particle formation replication • Genes are stably integrated into PT67 • Retroviral particles can infect target cells
  • 15. CULTURE CELLS • U937 cells possess the CCR5 gene but do not express receptor
  • 16. FUTURE PLANS • Test for presence of CCR5 in U937 cells